EUVIMEDEUVIMED entdecken
Crossref

miR-1236 regulates osteogenic and adipogenic differentiation by targeting BMP3 in osteoporotic fracture

Hongling Yan, Jing Wang, Yanan Xiao, Jinju Pang, Xiao Chang, Na Zhu iD

Journal of Endocrinology · 01.10.2026 · 271 (1)

DOI: 10.1530/joe-26-0228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 14.10.2026. Verfasst von Hongling Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Qingdao Municipal Hospital , Qingdao, China. Hauptthemen laut MEDLINE: MicroRNAs, Osteogenesis, Adipogenesis, Bone Morphogenetic Protein 3. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporotic fracture (OPF) has become a major global public health issue. We aim to investigate the serum expression and fracture risk association of miR-1236 in OPF and its mechanisms in bone metabolism. This study included 83 osteoporosis (OP) patients and 93 OPF patients. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to analyze gene expression levels. Lipofectamine 2000 was used to overexpress or inhibit miR-1236 in hFOB 1.19 human osteoblast cells and human bone marrow-derived mesenchymal stem cells (hBMSCs). Osteogenic differentiation was induced in hFOB 1.19 cells and adipogenic differentiation in hBMSCs. BMP3 was predicted as a target of miR-1236 by TargetScan and validated by a dual-luciferase reporter assay. Cell counting kit-8 (CCK-8) assay and flow cytometry were used to assess cell proliferation and apoptosis. We found that serum miR-1236 was downregulated in OPF patients. OPF patients presented elevated serum bone-metabolic markers (β-CTX, P1NP, and BMP3). miR-1236 was correlated with these bone-related markers in OPF patients. In hFOB 1.19 cells, miR-1236 promoted osteogenic differentiation. BMP3 was negatively regulated by miR-1236 and exerted an inhibitory effect on osteogenic differentiation. In hBMSCs, miR-1236 suppressed adipogenic differentiation, whereas BMP3 promoted adipogenic differentiation. In conclusion, serum miR-1236 decreased in patients with OPF and is correlated with altered bone-metabolic markers. In vitro findings demonstrate that miR-1236 promotes osteogenic differentiation and inhibits adipogenic differentiation by targeting BMP3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOsteogenesisAdipogenesisBone Morphogenetic Protein 3Osteoporotic FracturesHumansFemaleCell DifferentiationMesenchymal Stem CellsAgedMiddle AgedOsteoblastsMaleOsteoporosisCell ProliferationCells, Cultured

Stichwörter der Autor:innen

BMP3adipogenic differentiationmiR-1236osteogenic differentiationosteoporotic fractures

Substanzen

MicroRNAsBone Morphogenetic Protein 3

Autor:innen und Institutionen

  • Department of Endocrinology, Qingdao Municipal Hospital , Qingdao, China.
  • Department of Orthopedics, Qingdao West Coast New Area District Hospital , Qingdao, China.

ORCID-Profile: Na Zhu

Zitieren

APA

Yan, H., Wang, J., Xiao, Y., Pang, J., Chang, X., & Zhu, N. (2026). miR-1236 regulates osteogenic and adipogenic differentiation by targeting BMP3 in osteoporotic fracture. Journal of Endocrinology, 271(1). https://doi.org/10.1530/joe-26-0228

Vancouver

Yan H, Wang J, Xiao Y, Pang J, Chang X, Zhu N. miR-1236 regulates osteogenic and adipogenic differentiation by targeting BMP3 in osteoporotic fracture. Journal of Endocrinology. 2026;271(1). doi:10.1530/joe-26-0228

BibTeX
@article{Yan2026,
  author = {Yan, Hongling and Wang, Jing and Xiao, Yanan and Pang, Jinju and Chang, Xiao and Zhu, Na},
  title = {miR-1236 regulates osteogenic and adipogenic differentiation by targeting BMP3 in osteoporotic fracture},
  journal = {Journal of Endocrinology},
  year = {2026},
  volume = {271},
  number = {1},
  doi = {10.1530/joe-26-0228}
}
Kostenlos starten →